Current position of exctracorporeal membrane oxygenation (ECMO) in the treatment of respiratory and circulatory failure in children

Czech version

Authors: Vobruba Václav
Authors‘ workplace: Klinika dětského a dorostového lékařství Všeobecné fakultní nemocnice a 1. lékařské fakulty Univerzity Karlovy, Praha
Published in: Anest. intenziv. Med., 23, 2012, č. 3, s. 147-151
Category: Update in Intensive Care Medicine

Overview

Current knowledge of the exctracorporeal membrane oxygenation (ECMO) method, which is generally used in children, is reviewed in this article. A change in the spectrum of diseases indicated for ECMO therapy in children has been well documented during the past fifteen years. The number of chronically ill children undergoing ECMO is rising, the percentage of co-morbidity-free survivors out of the total ECMO survivor population has increased, survival among chronically ill children has decreased whereas the total number of treated children by ECMO has increased. The incidence of the veno-venous ECMO modality has risen compared to the venous-arterial ECMO modality which may lead to a significantly higher survival documented in children treated by veno-venous ECMO.

Keywords:
exctracorporeal membrane oxygenation (ECMO) – respiratory failure – cardiovasculary failure – children

Sources

1. Arnold, J. H., Anas, N. G., Luckett, P., Cheifetz, I. M., Reyes, G., Newth, C. J. L., Kocis, K. C., Heidemann, S. M., Hanson, J. H., Brogan, T. V. et al. High-frequency oscillatory ventilation in pediatric respiratory failure: A multicenter experience. Critical Care Medicine, 2000, 28, 12, p. 3913–3919.

2. Willson, D. F., Egan, E. A., Thomas, N. J., DiCarlo, J. V., Pon, S., Jefferson, L., Jacobs, B. Surfactant and pediatric acute lung injury – Reply. JAMA, 2005, 294, 8, p. 899–899.

3. Willson, D. F. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: A randomized controlled trial (vol 293, pg 470, 2005). JAMA, 2005, 294, 8, p. 900–900.

4. Sokol, J., Jacobs, S. E., Bohn, D. Inhaled nitric oxide for acute hypoxic respiratory failure in children and adults: A meta-analysis. Anest. Analg., 2003, 97, 4, p. 989–998.

5. Curley, M. A., Hibberd, P. L., Fineman, L. D., Wypij, D., Shih, M. C., Thompson, J. E., Grant, M. J., Barr, F. E., Cvijanovich, N. Z., Sorce, L. et al. Effect of prone positioning on clinical outcomes in children with acute lung injury: a randomized controlled trial. JAMA, 2005, 294, 2, p. 229–237.

6. Willson, D. F., Thomas, N. J., Markovitz, B. P., Bauman, L. A., DiCarlo, J. V., Pon, S., Jacobs, B. R., Jefferson, L. S., Conaway, M. R., Egan, E. A. et al. Effect of exogenous surfactant (Calfactant) in pediatric acute lung injury – a randomized controlled trial. JAMA, 2005, 293, 4, p. 470–476.

7. Zabrocki, L. A., Brogan, T. V., Statler, K. D., Poss, W. B., Rollins, M. D., Bratton, S. L. Extracorporeal membrane oxygenation for pediatric respiratory failure: Survival and predictors of mortality. Crit. Care Med., 2011, 39, 2, p. 364–370.

8. Bahrami, K. R., Van Meurs, K. P. ECMO for neonatal respiratory failure. Semin. Perinatol., 2005, 29, 1, p. 15–23.

9. Kolovos, N. S., Bratton, S. L., Moler, F. W., Bove, E. L., Ohye, R. G., Bartlett, R. H., Kulik, T. J. Outcome of pediatric patients treated with extracorporeal life support after cardiac surgery. Ann. Thor. Surg., 2003, 76, 5, p. 1435–1441.

10. Montgomery, V. L., Strotman, J. M., Ross, M. P. Impact of multiple organ system dysfunction and nosocomial infections on survival of children treated with extracorporeal membrane oxygenation after heart surgery. Crit. Care Med., 2000, 28, 2, p. 526–531.

11. Shah, S. A., Shankar, V., Churchwell, K. B., Taylor, M. B., Scott, B. P., Bartilson, R., Byrne, D. W., Christian, K. G., Drinkwater, D. C. Clinical outcomes of 84 children with congenital heart disease managed with extracorporeal membrane oxygenation after cardiac surgery. Asaio Journal, 2005, 51, 5, p. 504–507.

12. Aharon, A. S., Drinkwater, D. C., Churchwell, K. B., Quisling, S. V., Reddy, V. S., Taylor, M., Hix, S., Christian, K. G., Pietsch, J. B., Deshpande, J. K. et al. Extracorporeal membrane oxygenation in children after repair of congenital cardiac lesions. Ann. Thor. Surg., 2001, 72, 6, p. 2095–2101.

13. Zahraa, J. N., Moler, F. W., Annich, G. M., Maxvold, N. J., Bartlett, R. H., Custer, J. R. Venovenous versus venoarterial extracorporeal life support for pediatric respiratory failure: Are there differences in survival and acute complications? Crit. Care Med., 2000, 28, 2, p. 521–525.

14. Cengiz, P., Seidel, K., Rycus, P. T., Brogan, T. V., Roberts, J. S. Central nervous system complications during pediatric extracorporeal life support: Incidence and risk factors. Crit. Care Med., 2005, 33, 12, p. 2817–2824.

15. Watson, R. S., Carcillo, J. A., Linde-Zwirble, W. T., Clermont, G., Lidicker, J., Angus, D. C. The epidemiology of severe sepsis in children in the United States. Am. J. Respirat. Crit. Care Med., 2003, 167, 5, p. 695–701.

16. Goldman, A. P., Kerr, S. J., Butt, W., Marsh, M. J., Murdoch, I. A., Paul, T., Firmin, R. K., Tasker, R. C., Macrae, D. J. Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease. Lancet, 1997, 349, 9050, p. 466–469.

17. MacLaren, G., Butt, W., Best, D., Donath, S., Taylor, A. Extracorporeal membrane oxygenation for refractory septic shock in children: One institution’s experience. Pediatr. Crit. Care Med., 2007, 8, 5, p. 447–451.

18. Brierley, J., Carcillo, J. A., Choong, K., Cornell, T., DeCaen, A., Deymann, A., Doctor, A., Davis, A., Duff, J., Dugas, M. A. et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit. Care Med., 2009, 37, 2, p. 666–688.

19. MacLaren, G., Butt, W. Central extracorporeal membrane oxygenation for refractory pediatric septic shock Reply. Pediatr. Crit. Care Med., 2011, 12, 5, p. 606–607.

20. Champion, M. P., Murdoch, I. A., Sajjanhar, T., Marsh, M. J. Extracorporeal membrane oxygenation for refractory shock in fulminant meningococcal sepsis. Lancet, 1996, 347, 8995, p. 201–202.

21. Asaumi, Y., Yasuda, S., Morii, I., Kakuchi, H., Otsuka, Y., Kawamura, A., Sasako, Y., Nakatani, T., Nonogi, H., Miyazaki, S. Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation. Europ. Heart J., 2005, 26, 20, p. 2185–2192.

22. Magnani, J. W., Dec, G. W. Myocarditis – Current trends in diagnosis and treatment. Circulation, 2006, 113, 6, p. 876–890.

23. Kuhn, B., Shapiro, E. D., Walls, T. A., Friedman, A. H. Predictors of outcome of myocarditis. Pediatr. Cardiology, 2004, 25, 4, p. 379–384.

24. Lin, C. H., Chang, J. S., Li, P. C. The rescue of acute fulminant myocarditis by extracorporeal membrane oxygenation in pediatric patients. Acta Paediatr Taiwan, 2005, 46, 4, p. 201–205.

25. Rajagopal, S. K., Almond, C. S., Laussen, P. C., Rycus, P. T., Wypij, D., Thiagarajan, R. R. Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: A review of the Extracorporeal Life Support Organization registry. Crit. Care Med., 2010, 38, 2, p. 382–387.

26. Bowles, N. E., Ni, J., Kearney, D. L., Pauschinger, M., Schultheiss, H. P., McCarthy, R., Hare, J., Bricker, J. T., Bowles, K. R., Towbin, J. A. Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J. Am. Coll. Cardiol., 2003, 42, 3, p. 466–472.

27. Hetzer, R., Stiller, B. Technology insight: use of ventricular assist devices in children. Nat. Clin. Pract. Cardiovasc. Med., 2006, 3, 7, p. 377–386.

28. Smith, M., Hare, M. L. An overview of progress in childhood cancer survival. J. Pediatr. Oncol. Nurs., 2004, 21, 3, p. 160–164.

29. Gow, K. W., Heiss, K. F., Wulkan, M. L., Katzenstein, H. M., Rosenberg, E. S., Heard, M. L., Rycus, P. T., Fortenberry, J. D. The extracorporeal life support experience. Extracorporeal life support for support of children with malignancy and respiratory or cardiac failure: Crit. Care Med., 2009, 37, 4, p. 1308–1316.

Labels

Anaesthesiology, Resuscitation and Inten Intensive Care Medicine

How to perform daily rounds in the ICU?

Mechanical circulatory support devices

Therapeutical hypothermia after cardiac arrest

Blood transfusion in children and neonates

Article was published in

Anaesthesiology and Intensive Care Medicine

2012 Issue 3